LauraAnnSassMD
Pediatric Infectious Disease • Norfolk, VAMedical Director, IPAC Medical Director, Antibiotic Stewardship Associate Center Director, CHKD Pediatric CF Center
Dr. Sass is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Childrens Ln
Norfolk, VA 23507Phone+1 757-668-7238Fax+1 757-668-8275
Summary
- Dr. Laura Sass is a pediatric infectious disease specialist in Norfolk, VA and is affiliated with Children's Hospital of The King's Daughters. She received her medical degree from George Washington University School of Medicine and has been in practice 20 years. She is experienced in cystic fibrosis and pediatric infectious disease.
Education & Training
Eastern Virginia Medical SchoolFellowship, Pediatric Infectious Diseases, 2000 - 2004- Eastern Virginia Medical SchoolResidency, Pediatrics, 1997 - 2000
George Washington University School of Medicine and Health SciencesClass of 1997
Certifications & Licensure
VA State Medical License 1997 - 2026
NC State Medical License 2020 - 2022
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis Start of enrollment: 2014 Jun 01
- AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis Start of enrollment: 2017 Sep 20
Publications & Presentations
PubMed
- 1 citationsPreliminary evidence for sustained efficacy of CFTR modulator therapy with concomitant rifabutin administration.Eunjin Hong, Sarah M Parsons, Laura Sass, Cynthia Epstein, Lynn Chan
Journal of Cystic Fibrosis. 2024-05-01 - 1 citationsReal-world effectiveness of elexacaftor/tezacaftor/ivacaftor on the burden of illness in adolescents and adults with cystic fibrosis.Thomas Keens, Veena Hoffman, Ia Topuria, Ken Elder, Shannon Cerf
Heliyon. 2024-04-15 - Not Always Sepsis: A Febrile Neonate With a Persistent Cough.Daley Auvil, Kyrie Shomaker, Jennifer Bleznak, Lauren Smith, Laura Sass
Clinical Pediatrics. 2023-12-01
Press Mentions
- Around Virginia, Respiratory Illnesses Surge Among ChildrenOctober 31st, 2022
- Home for the Holidays? Here Are Some Tips to Stay SafeNovember 22nd, 2021
- Virginia’s New Data Tool Fixed After Vastly Underreporting Children Hospitalized with COVID-19October 19th, 2021
- Join now to see all
Professional Memberships
- Fellow
- Pediatric Infectious Disease SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
